Protalix Biotherapeutics Inc (NYSE American:PLX)

0.4258
Delayed Data
As of Apr 20
 -0.015 / -3.40%
Today’s Change
0.42
Today|||52-Week Range
1.06
-35.60%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Protalix Biotherapeutics Inc have a median target of 3.55, with a high estimate of 5.00 and a low estimate of 2.10. The median estimate represents a +733.72% increase from the last price of 0.43.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Protalix Biotherapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$10.0M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 45.45%
 
 
 
 
 
 
Growthannually 41.67%
 
 
 
 
 
 

Sales

Growthquarterly 206.75%
 
 
 
 
 
 
Growthannually 53.57%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.